Related Experiment Video
Updated: Jul 8, 2025
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Monkeypox (Mpox) Vaccine Hesitancy Among Mpox Cases: A Qualitative Study
Harit Agroia1,2, Emily Smith1, Akanksha Vaidya1
1County of Santa Clara Public Health Department, San Jose, CA, USA.
Mpox vaccine hesitancy is high among cases in California due to lack of perceived risk, limited access, and stigma. Tailored education is recommended to increase mpox vaccination rates.
Area of Science:
- Public Health
- Infectious Diseases
- Vaccinology
Background:
- Human mpox (monkeypox) has emerged as a significant public health concern.
- Vaccine hesitancy impacts uptake of the Jynneos vaccine, despite its cross-protection capabilities.
Purpose of the Study:
- To assess knowledge, facilitators, and barriers to mpox vaccine uptake.
- Focus on individuals previously diagnosed with mpox in Santa Clara County, California.
Main Methods:
- In-depth interviews conducted with mpox cases diagnosed between July-September 2022.
- Grounded theory data analysis approach used for response interpretation.
Main Results:
- 77% heard of mpox pre-diagnosis; 56% did not perceive personal risk.
- Vaccine access and availability were primary barriers for non-recipients.
- Hesitancy reasons included perceived risk, stigma (branding, gay labeling), and safety concerns.
Conclusions:
- Key mpox vaccine hesitancy factors include lack of awareness, perceived risk, accessibility issues, and stigma.
- Targeted outreach and educational campaigns are crucial to address these specific concerns and improve vaccination coverage.
More Related Videos
12:00Vaccinia Virus Infection & Temporal Analysis of Virus Gene Expression: Part 1
Published on: April 8, 2009
08:10Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
Published on: November 28, 2018
